DrHannah Cheeseman
Postdoctoral Researcher & Clinical Trials Laboratory Manager
Department of Infectious Disease - Faculty of Medicine
Orcid identifier0000-0001-9044-1341 (opens in a new tab)
- Postdoctoral Researcher & Clinical Trials Laboratory ManagerDepartment of Infectious Disease - Faculty of Medicine
- 020 7594 2540 (Work)
- Imperial College London, Infectious Disease - Shattock Group, Office 144, Sir Alexander Fleming Building, London, South Kensington Campus, SW7 2AZ, United Kingdom
RESEARCH
Dr Hannah Cheeseman leads the Core Immunology Laboratory within Professor Robin Shattock’s Group of Mucosal Infection and Immunity in the Department of Infectious Disease. Her primary research centres on human clinical vaccine trials for the development of new vaccine candidates, with a particular focus on the generation of systemic and mucosal vaccine-induced immunity.
Hannah was awarded a B.Sc. (Hons) in Veterinary Pathogenesis from Bristol University and an M.Sc. in Immunology and Allergy from the University of Nottingham. Hannah then spent six years working at the International AIDS Vaccine Initiative Human Immunology Laboratory (IAVI HIL) at Imperial College London before leaving to join Professor Robin Shattock’s team as a PhD student and research assistant. Having gained her PhD in Mucosal Immunology, Hannah took over the running of the Core Immunology Laboratory in 2016.
Hannah is currently involved in several research programs awarded to Professor Robin Shattock and funded by Innovate UK, CEPI, EAVI2020, EPSRC and NIHR. These aim to investigate vaccine-induced immunity via human clinical trials to infectious diseases including Ebola, Lassa, Marburg, Rabies, HIV-1 and SARS-CoV-2. Self-amplifying RNA (saRNA) and mRNA vaccine platforms are the primary focus of the current clinical trials.
Hannah was awarded a B.Sc. (Hons) in Veterinary Pathogenesis from Bristol University and an M.Sc. in Immunology and Allergy from the University of Nottingham. Hannah then spent six years working at the International AIDS Vaccine Initiative Human Immunology Laboratory (IAVI HIL) at Imperial College London before leaving to join Professor Robin Shattock’s team as a PhD student and research assistant. Having gained her PhD in Mucosal Immunology, Hannah took over the running of the Core Immunology Laboratory in 2016.
Hannah is currently involved in several research programs awarded to Professor Robin Shattock and funded by Innovate UK, CEPI, EAVI2020, EPSRC and NIHR. These aim to investigate vaccine-induced immunity via human clinical trials to infectious diseases including Ebola, Lassa, Marburg, Rabies, HIV-1 and SARS-CoV-2. Self-amplifying RNA (saRNA) and mRNA vaccine platforms are the primary focus of the current clinical trials.